Rifan Muazin

Toward a Global Shield: WHO Nations Make Strides on Pathogen Access and Benefit Sharing Framework

• Breast Cancer Prevention and Lifestyle

Toward a Global Shield: WHO Nations Make Strides on Pathogen Access and Benefit Sharing Framework

Rifan Muazin July 27, 2026

GENEVA – In a high-stakes diplomatic effort to fortify the world against future biological threats, Member States...

Read More Read more about Toward a Global Shield: WHO Nations Make Strides on Pathogen Access and Benefit Sharing Framework

Shaping the Future of Global Health: Key Outcomes from the World Health Assembly

• Global Breast Cancer Awareness

Shaping the Future of Global Health: Key Outcomes from the World Health Assembly

Rifan Muazin July 27, 2026

The World Health Assembly, the supreme decision-making body of the World Health Organization (WHO), recently concluded a...

Read More Read more about Shaping the Future of Global Health: Key Outcomes from the World Health Assembly

Advancing the Frontier of Metastatic Breast Cancer Research: A Report on Advocacy, Innovation, and Patient-Centered Science

• Patient Advocacy and Support

Advancing the Frontier of Metastatic Breast Cancer Research: A Report on Advocacy, Innovation, and Patient-Centered Science

Rifan Muazin July 26, 2026

Introduction: The Urgent Mandate of METAvivor In the landscape of oncology, metastatic breast cancer (MBC)—cancer that has...

Read More Read more about Advancing the Frontier of Metastatic Breast Cancer Research: A Report on Advocacy, Innovation, and Patient-Centered Science

Bioinformatics: Navigating the Frontier of Modern Healthcare with Fern Kirkham

• Genomics and Precision Medicine

Bioinformatics: Navigating the Frontier of Modern Healthcare with Fern Kirkham

Rifan Muazin July 26, 2026

In the rapidly evolving landscape of modern medicine, few disciplines have witnessed as dramatic an expansion as...

Read More Read more about Bioinformatics: Navigating the Frontier of Modern Healthcare with Fern Kirkham

Johnson & Johnson’s Talvey and Tecvayli Regimens Show Significant Promise in Earlier Multiple Myeloma Treatment Lines

• Medical Research and Clinical Trials

Johnson & Johnson’s Talvey and Tecvayli Regimens Show Significant Promise in Earlier Multiple Myeloma Treatment Lines

Rifan Muazin July 25, 2026

New Phase III data from the MonumenTAL-6 study heralds a potential paradigm shift in multiple myeloma therapy,...

Read More Read more about Johnson & Johnson’s Talvey and Tecvayli Regimens Show Significant Promise in Earlier Multiple Myeloma Treatment Lines

Beyond the Diagnosis: Lessons in Community and Care Amidst a Cancer Journey

• Survivorship and Post-Treatment

Beyond the Diagnosis: Lessons in Community and Care Amidst a Cancer Journey

Rifan Muazin July 25, 2026

By Editorial Staff October 06, 2025 The diagnosis of breast cancer is frequently described as a singular...

Read More Read more about Beyond the Diagnosis: Lessons in Community and Care Amidst a Cancer Journey

The Invisible Giant: Why Hospital Costs Remain in the Shadows While Drug Prices Dominate the Discourse

• Breast Cancer Legislation and Policy

The Invisible Giant: Why Hospital Costs Remain in the Shadows While Drug Prices Dominate the Discourse

Rifan Muazin July 24, 2026

By Editorial Staff Published: July 16, 2026 In the ongoing debate over the skyrocketing cost of healthcare...

Read More Read more about The Invisible Giant: Why Hospital Costs Remain in the Shadows While Drug Prices Dominate the Discourse

Eli Lilly’s Retatrutide Achieves Major Milestones in Type 2 Diabetes and Obesity Trials, Paving the Way for Potential Market Dominance

• Medical Research and Clinical Trials

Eli Lilly’s Retatrutide Achieves Major Milestones in Type 2 Diabetes and Obesity Trials, Paving the Way for Potential Market Dominance

Rifan Muazin July 23, 2026

Indianapolis, IN – [Date] – Eli Lilly and Company is poised to further solidify its commanding presence...

Read More Read more about Eli Lilly’s Retatrutide Achieves Major Milestones in Type 2 Diabetes and Obesity Trials, Paving the Way for Potential Market Dominance

Nuvation Bio Accelerates Glioma Drug Development with Pivotal Global Trial and New Phase II Study

• Medical Research and Clinical Trials

Nuvation Bio Accelerates Glioma Drug Development with Pivotal Global Trial and New Phase II Study

Rifan Muazin July 20, 2026

San Francisco, CA – [Insert Date] – Nuvation Bio, a clinical-stage biopharmaceutical company, is significantly expanding its...

Read More Read more about Nuvation Bio Accelerates Glioma Drug Development with Pivotal Global Trial and New Phase II Study

Bridging the Gap Between Advocacy and Science: Dr. Kelly Shanahan Outlines Vision for 2026 Research Milestones

• Patient Advocacy and Support

Bridging the Gap Between Advocacy and Science: Dr. Kelly Shanahan Outlines Vision for 2026 Research Milestones

Rifan Muazin July 19, 2026

By [Your Name/Agency] The landscape of metastatic breast cancer (MBC) research is undergoing a seismic shift, driven...

Read More Read more about Bridging the Gap Between Advocacy and Science: Dr. Kelly Shanahan Outlines Vision for 2026 Research Milestones